November 8, 2014
Patient Compliance/*statistics & numerical data
Notes: Cronin, Patrick R
Kimball, Alexa Boer
Research Support, Non-U.S. Gov’t
JAMA Dermatol. 2013 Dec;149(12):1435-7. doi: 10.1001/jamadermatol.2013.5771.
Author Address: Practice Improvement Division, Massachusetts General Hospital, Boston2now with Lab of Computer Science, Massachusetts General Hospital, Boston.
College of the Holy Cross, Worcester, Massachusetts4now with University of Massachusetts Medical School, Worcester.
Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston.
Reference Type: Journal Article
Record Number: 4241Author: Czaika, V., Nenoff, P., Glockner, A., Fegeler, W., Becker, K. and Schmalreck, A. F.
Title: Epidemiology and changes in patient-related factors from 1997 to 2009 in clinical yeast isolates related to dermatology, gynaecology, and paediatrics
Journal: Int J Microbiol
Short Title: Epidemiology and changes in patient-related factors from 1997 to 2009 in clinical yeast isolates related to dermatology, gynaecology, and paediatrics
Alternate Journal: International journal of microbiology
ISSN: 1687-918X (Print)
Accession Number: 24391669
Abstract: From 1997 to 2009, 1,862 dermatology, gynaecology, and paediatrics (DGP) associated clinical yeast isolates were analysed for species occurrence, specimen origin and type, (multi-) resistance pattern, and testing period. The top seven of the isolated DGP-associated species remained the same as compared to total medical wards, with Candida albicans (45%) as most frequent pathogen. However, the DGP wards and DGP ICUs showed species-specific profiles; that is, the species distribution is clinic-specific similar and however differs in their percentage from ward to ward. By applying the “one fungus one name” principle, respectively, the appropriate current taxonomic species denominations, it has been shown that no trend to emerging species from 1998 to 2008 could be detected. In particular the frequently isolated non-Candida albicans species isolated in the DGP departments have already been detected in or before 1997. As yeasts are part of the cutaneous microbiota and play an important role as opportunistic pathogens for superficial infections, proper identification of the isolates according to the new nomenclature deems to be essential for specific and calculated antifungal therapy for yeast-like DGP-related infectious agents.